266 related articles for article (PubMed ID: 15701836)
1. Expression and signaling activity of Wnt-5a/discoidin domain receptor-1 and Syk plays distinct but decisive roles in breast cancer patient survival.
Dejmek J; Leandersson K; Manjer J; Bjartell A; Emdin SO; Vogel WF; Landberg G; Andersson T
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):520-8. PubMed ID: 15701836
[TBL] [Abstract][Full Text] [Related]
2. Wnt-5a and G-protein signaling are required for collagen-induced DDR1 receptor activation and normal mammary cell adhesion.
Dejmek J; Dib K; Jönsson M; Andersson T
Int J Cancer; 2003 Jan; 103(3):344-51. PubMed ID: 12471617
[TBL] [Abstract][Full Text] [Related]
3. Growth-related oncogene produced in human breast cancer cells and regulated by Syk protein-tyrosine kinase.
Li J; Sidell N
Int J Cancer; 2005 Oct; 117(1):14-20. PubMed ID: 15880583
[TBL] [Abstract][Full Text] [Related]
4. Repression of Wnt-5a impairs DDR1 phosphorylation and modifies adhesion and migration of mammary cells.
Jönsson M; Andersson T
J Cell Sci; 2001 Jun; 114(Pt 11):2043-53. PubMed ID: 11493640
[TBL] [Abstract][Full Text] [Related]
5. Migration inhibition of mammary epithelial cells by Syk is blocked in the presence of DDR1 receptors.
Neuhaus B; Bühren S; Böck B; Alves F; Vogel WF; Kiefer F
Cell Mol Life Sci; 2011 Nov; 68(22):3757-70. PubMed ID: 21499918
[TBL] [Abstract][Full Text] [Related]
6. Cross-linking of integrins induces tyrosine phosphorylation of the proto-oncogene product Vav and the protein tyrosine kinase Syk in human factor-dependent myeloid cells.
Gotoh A; Takahira H; Geahlen RL; Broxmeyer HE
Cell Growth Differ; 1997 Jun; 8(6):721-9. PubMed ID: 9186005
[TBL] [Abstract][Full Text] [Related]
7. Wnt-5a-CKI{alpha} signaling promotes {beta}-catenin/E-cadherin complex formation and intercellular adhesion in human breast epithelial cells.
Medrek C; Landberg G; Andersson T; Leandersson K
J Biol Chem; 2009 Apr; 284(16):10968-79. PubMed ID: 19244247
[TBL] [Abstract][Full Text] [Related]
8. The Wnt-5a-derived hexapeptide Foxy-5 inhibits breast cancer metastasis in vivo by targeting cell motility.
Säfholm A; Tuomela J; Rosenkvist J; Dejmek J; Härkönen P; Andersson T
Clin Cancer Res; 2008 Oct; 14(20):6556-63. PubMed ID: 18927296
[TBL] [Abstract][Full Text] [Related]
9. Alternative splicing disrupts a nuclear localization signal in spleen tyrosine kinase that is required for invasion suppression in breast cancer.
Wang L; Duke L; Zhang PS; Arlinghaus RB; Symmans WF; Sahin A; Mendez R; Dai JL
Cancer Res; 2003 Aug; 63(15):4724-30. PubMed ID: 12907655
[TBL] [Abstract][Full Text] [Related]
10. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.
Schlange T; Matsuda Y; Lienhard S; Huber A; Hynes NE
Breast Cancer Res; 2007; 9(5):R63. PubMed ID: 17897439
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of signaling through the B cell antigen receptor by the protooncogene product, c-Cbl, requires Syk tyrosine 317 and the c-Cbl phosphotyrosine-binding domain.
Yankee TM; Keshvara LM; Sawasdikosol S; Harrison ML; Geahlen RL
J Immunol; 1999 Dec; 163(11):5827-35. PubMed ID: 10570266
[TBL] [Abstract][Full Text] [Related]
12. Fgr but not Syk tyrosine kinase is a target for beta 2 integrin-induced c-Cbl-mediated ubiquitination in adherent human neutrophils.
Melander F; Andersson T; Dib K
Biochem J; 2003 Mar; 370(Pt 2):687-94. PubMed ID: 12435267
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of co-expression of RON and MET receptors in node-negative breast cancer patients.
Lee WY; Chen HH; Chow NH; Su WC; Lin PW; Guo HR
Clin Cancer Res; 2005 Mar; 11(6):2222-8. PubMed ID: 15788670
[TBL] [Abstract][Full Text] [Related]
14. Regulation of the pp72syk protein tyrosine kinase by platelet integrin alpha IIb beta 3.
Gao J; Zoller KE; Ginsberg MH; Brugge JS; Shattil SJ
EMBO J; 1997 Nov; 16(21):6414-25. PubMed ID: 9351824
[TBL] [Abstract][Full Text] [Related]
15. Wnt-5a mRNA translation is suppressed by the Elav-like protein HuR in human breast epithelial cells.
Leandersson K; Riesbeck K; Andersson T
Nucleic Acids Res; 2006; 34(14):3988-99. PubMed ID: 16914445
[TBL] [Abstract][Full Text] [Related]
16. Wnt5a is required for proper mammary gland development and TGF-beta-mediated inhibition of ductal growth.
Roarty K; Serra R
Development; 2007 Nov; 134(21):3929-39. PubMed ID: 17898001
[TBL] [Abstract][Full Text] [Related]
17. Loss of Wnt-5a protein is associated with early relapse in invasive ductal breast carcinomas.
Jönsson M; Dejmek J; Bendahl PO; Andersson T
Cancer Res; 2002 Jan; 62(2):409-16. PubMed ID: 11809689
[TBL] [Abstract][Full Text] [Related]
18. Wnt-5a signaling restores tamoxifen sensitivity in estrogen receptor-negative breast cancer cells.
Ford CE; Ekström EJ; Andersson T
Proc Natl Acad Sci U S A; 2009 Mar; 106(10):3919-24. PubMed ID: 19237581
[TBL] [Abstract][Full Text] [Related]
19. Progressive loss of Syk and abnormal proliferation in breast cancer cells.
Moroni M; Soldatenkov V; Zhang L; Zhang Y; Stoica G; Gehan E; Rashidi B; Singh B; Ozdemirli M; Mueller SC
Cancer Res; 2004 Oct; 64(20):7346-54. PubMed ID: 15492255
[TBL] [Abstract][Full Text] [Related]
20. Protein tyrosine kinase Syk modulates EGFR signalling in human mammary epithelial cells.
Ruschel A; Ullrich A
Cell Signal; 2004 Nov; 16(11):1249-61. PubMed ID: 15337524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
